Is RNA the answer to cancer?
Join our panel of experts as they discuss how RNA technologies, combined with other drugs, can help in the fight against cancer.
Until recently most people had never heard of RNA.
If DNA is the hardware of life, then RNA is the software that allows it to operate. mRNA is well-known as the key ingredient in COVID-19 vaccines. But RNA technology could also play an important role in how we treat other conditions such as cancer, cystic fibrosis and schizophrenia.
UNSW researchers discuss the advancement of RNA technologies, including how it might combine with other drugs in the fight against hard-to-treat cancers.
Led by Tegan Taylor, Health and Science reporter for the ABC, hear from panellists Professor Palli Thordarson, Director of the UNSW RNA Institute; Conjoint Professor Maria Kavallaris AM, Head of Translational Cancer NanoMedicine Theme and UNSW Children's Cancer Institute; and Associate Professor Joshua McCarroll, Team Leader at Children’s Cancer Institute and Conjoint Associate Professor at UNSW Medicine & Health. Josh is a survivor of childhood cancer and understands better than most the importance of finding new cures and treatments for this most devastating of childhood diseases.